Adapthealth Corp (AHCO)

$10.76

-0.24

(-2.18%)▲

Live

Performance

  • $10.75
    $10.95
    $10.76
    downward going graph

    0.14%

    Downside

    Day's Volatility :1.83%

    Upside

    1.69%

    downward going graph
  • $6.37
    $11.90
    $10.76
    downward going graph

    40.8%

    Downside

    52 Weeks Volatility :46.47%

    Upside

    9.58%

    downward going graph

Returns

PeriodAdapthealth CorpSector (Health Care)Index (Russel 2000)
3 Months
-0.9%
3.6%
0.0%
6 Months
14.58%
10.2%
0.0%
1 Year
46.86%
19.6%
0.0%
3 Years
-57.36%
16.8%
-23.0%

Highlights

Market Capitalization
1.5B
Book Value
$11.48
Earnings Per Share (EPS)
-5.22
Wall Street Target Price
12.44
Profit Margin
-21.2%
Operating Margin TTM
8.41%
Return On Assets TTM
3.71%
Return On Equity TTM
-37.34%
Revenue TTM
3.3B
Revenue Per Share TTM
24.43
Quarterly Revenue Growth YOY
1.6%
Gross Profit TTM
490.8M
EBITDA
662.1M
Diluted Eps TTM
-5.22
Quarterly Earnings Growth YOY
0.44
EPS Estimate Current Year
0.59
EPS Estimate Next Year
1.0
EPS Estimate Current Quarter
0.16
EPS Estimate Next Quarter
0.17

Analyst Recommendation

Buy
    68%Buy
    25%Hold
    6%Sell
Based on 16 Wall street analysts offering stock ratings for Adapthealth Corp(by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
4
4
4
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 15.61%

Current $10.76
Target $12.44

Company Financials

FY18Y/Y Change
Revenue
345.3M
↑ 79.31%
Net Income
2.1M
↓ 302432.46%
Net Profit Margin
0.6%
↑ 0.6%
FY19Y/Y Change
Revenue
529.6M
↑ 53.4%
Net Income
12.2M
↑ 486.6%
Net Profit Margin
2.31%
↑ 1.71%
FY20Y/Y Change
Revenue
1.1B
↑ 99.45%
Net Income
-58.7M
↓ 579.84%
Net Profit Margin
-5.56%
↓ 7.87%
FY21Y/Y Change
Revenue
2.5B
↑ 132.35%
Net Income
156.2M
↓ 365.97%
Net Profit Margin
6.36%
↑ 11.92%
FY22Y/Y Change
Revenue
3.0B
↑ 21.02%
Net Income
69.3M
↓ 55.62%
Net Profit Margin
2.33%
↓ 4.03%
FY23Y/Y Change
Revenue
3.2B
↑ 7.73%
Net Income
-678.9M
↓ 1079.42%
Net Profit Margin
-21.21%
↓ 23.54%
Q1 FY23Q/Q Change
Revenue
744.6M
↓ 4.57%
Net Income
15.7M
↓ 1099.81%
Net Profit Margin
2.11%
↑ 2.31%
Q2 FY23Q/Q Change
Revenue
793.3M
↑ 6.53%
Net Income
14.0M
↓ 11.01%
Net Profit Margin
1.76%
↓ 0.35%
Q3 FY23Q/Q Change
Revenue
804.0M
↑ 1.35%
Net Income
-454.1M
↓ 3348.74%
Net Profit Margin
-56.47%
↓ 58.23%
Q4 FY23Q/Q Change
Revenue
858.2M
↑ 6.74%
Net Income
-254.5M
↓ 43.95%
Net Profit Margin
-29.65%
↑ 26.82%
Q1 FY24Q/Q Change
Revenue
792.5M
↓ 7.66%
Net Income
-2.1M
↓ 99.16%
Net Profit Margin
-0.27%
↑ 29.38%
Q2 FY24Q/Q Change
Revenue
806.0M
↑ 1.7%
Net Income
19.4M
↓ 1010.73%
Net Profit Margin
2.41%
↑ 2.68%
FY18Y/Y Change
Total Assets
254.1M
↑ 81713.0%
Total Liabilities
8.6M
↑ 2894.8%
FY19Y/Y Change
Total Assets
227.8M
↓ 10.34%
Total Liabilities
212.7M
↑ 2380.62%
FY20Y/Y Change
Total Assets
1.8B
↑ 701.57%
Total Liabilities
1.4B
↑ 573.03%
FY21Y/Y Change
Total Assets
5.3B
↑ 187.5%
Total Liabilities
3.2B
↑ 122.41%
FY22Y/Y Change
Total Assets
5.2B
↓ 0.59%
Total Liabilities
3.1B
↓ 3.83%
FY23Y/Y Change
Total Assets
4.6B
↓ 11.49%
Total Liabilities
3.2B
↑ 2.98%
Q1 FY23Q/Q Change
Total Assets
5.3B
↑ 1.22%
Total Liabilities
3.1B
↑ 1.77%
Q2 FY23Q/Q Change
Total Assets
5.2B
↓ 1.52%
Total Liabilities
3.0B
↓ 3.21%
Q3 FY23Q/Q Change
Total Assets
4.7B
↓ 9.18%
Total Liabilities
3.0B
↓ 1.01%
Q4 FY23Q/Q Change
Total Assets
4.6B
↓ 2.23%
Total Liabilities
3.2B
↑ 5.62%
Q1 FY24Q/Q Change
Total Assets
4.5B
↓ 2.51%
Total Liabilities
3.0B
↓ 3.82%
Q2 FY24Q/Q Change
Total Assets
4.5B
↑ 0.16%
Total Liabilities
3.0B
↓ 0.47%
FY18Y/Y Change
Operating Cash Flow
68.4M
↑ 48.98%
Investing Cash Flow
-96.3M
↑ 538.6%
Financing Cash Flow
251.3M
↑ 209657.17%
FY19Y/Y Change
Operating Cash Flow
60.4M
↓ 11.7%
Investing Cash Flow
-84.9M
↓ 11.85%
Financing Cash Flow
-13.9M
↓ 105.53%
FY20Y/Y Change
Operating Cash Flow
195.6M
↑ 223.8%
Investing Cash Flow
-815.7M
↑ 861.12%
Financing Cash Flow
643.2M
↓ 4729.33%
FY21Y/Y Change
Operating Cash Flow
275.7M
↑ 40.92%
Investing Cash Flow
-1.8B
↑ 123.7%
Financing Cash Flow
1.6B
↑ 148.58%
FY22Y/Y Change
Operating Cash Flow
373.9M
↑ 35.62%
Investing Cash Flow
-411.2M
↓ 77.47%
Financing Cash Flow
-66.1M
↓ 104.13%
Q1 FY23Q/Q Change
Operating Cash Flow
140.2M
↑ 44.7%
Investing Cash Flow
-89.6M
↓ 38.57%
Financing Cash Flow
4.4M
↓ 128.53%
Q2 FY23Q/Q Change
Operating Cash Flow
86.3M
↓ 38.45%
Investing Cash Flow
-100.2M
↑ 11.87%
Financing Cash Flow
-42.4M
↓ 1053.19%

Technicals Summary

Sell

Neutral

Buy

Adapthealth Corp is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Adapthealth Corp
Adapthealth Corp
-0.99%
14.58%
46.86%
-57.36%
14.58%
Stryker Corporation
Stryker Corporation
0.83%
12.78%
40.21%
33.69%
71.83%
Boston Scientific Corp.
Boston Scientific Corp.
4.85%
29.48%
75.68%
96.28%
127.87%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
4.32%
-19.19%
1.77%
-39.29%
-7.22%
Abbott Laboratories
Abbott Laboratories
3.99%
11.51%
24.65%
-4.53%
46.22%
Medtronic Plc
Medtronic Plc
2.65%
14.48%
27.42%
-24.18%
-13.49%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Adapthealth Corp
Adapthealth Corp
64.08
NA
NA
0.59
-0.37
0.04
NA
11.48
Stryker Corporation
Stryker Corporation
40.15
40.15
2.64
12.01
0.19
0.07
0.01
51.86
Boston Scientific Corp.
Boston Scientific Corp.
70.26
70.26
2.14
2.41
0.09
0.05
NA
13.85
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
27.67
27.67
3.65
2.6
0.22
0.12
NA
12.35
Abbott Laboratories
Abbott Laboratories
35.83
35.83
4.31
4.67
0.14
0.06
0.02
22.26
Medtronic Plc
Medtronic Plc
30.23
30.23
1.67
5.2
0.08
0.04
0.03
37.39
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Adapthealth Corp
Adapthealth Corp
Buy
$1.5B
14.58%
64.08
-21.2%
Stryker Corporation
Stryker Corporation
Buy
$137.1B
71.83%
40.15
16.12%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$127.3B
127.87%
70.26
12.0%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$42.3B
-7.22%
27.67
23.74%
Abbott Laboratories
Abbott Laboratories
Buy
$205.1B
46.22%
35.83
13.65%
Medtronic Plc
Medtronic Plc
Buy
$115.2B
-13.49%
30.23
12.06%

Insights on Adapthealth Corp

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 792.49M → 805.97M (in $), with an average increase of 1.7% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -454.07M → 19.43M (in $), with an average increase of 4005.2% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 76.0% return, outperforming this stock by 32.0%

  • Vs BSX

    In the last 3 years, Boston Scientific Corp. has given 96.3% return, outperforming this stock by 153.7%

Institutional Holdings

  • OEP CAPITAL ADVISORS, L.P.

    10.28%

  • BlackRock Inc

    10.10%

  • Deerfield Management Co

    9.86%

  • Vanguard Group Inc

    7.95%

  • FMR Inc

    5.00%

  • Reinhart Mahoney Capital Management Inc

    4.61%

Company Information

at adapthealth, we believe everyone deserves a comfortable and independent life with access to products and services tailored to empower patients to live their best lives -- out of the hospital and in their homes. we are a full-service home medical equipment and respiratory company with operations in 46 states offering a breadth of clinically-focused products and services to help patients with daily activities of life including: sleep and respiratory therapy, mobility products, wound care, non-invasive ventilation and nutrition.

Organization
Adapthealth Corp
Employees
10700
CEO
Mr. Jason A. Clemens C.F.A.
Industry
Finance

Discover More

FAQs